NCT05130762

A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 157 (actual)
• Sponsor: Becton, Dickinson and Company · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The study will collect use data of the Becton Dickinson (BD) PureHub™ Disinfecting Cap in combination with needle-free connectors, which are attached to vascular access devices (VAD).

Detailed description

This is a multi-center, prospective observational study of a minimum of 150 study participants who have vascular access devices (VADs) with needle-free connectors as part of their routine medical care. Patients will be followed from the time of enrollment through the duration of VAD therapy or 45 days post enrollment date, whichever comes first.

Conditions

• Catheter Related Complication
• Vascular Access Site Management
• Disinfecting Cap

Interventions

Type	Name	Description
DEVICE	BD PureHub™ Disinfecting Cap Placements: Attachments/removals	Attachment/Removals of BD PureHub™ Disinfecting Cap

Timeline

• Start date: 2022-01-31
• Primary completion: 2023-05-22
• Completion: 2023-05-22
• First posted: 2021-11-23
• Last updated: 2025-01-27
• Results posted: 2025-01-27

Locations

5 sites across 4 countries: Austria, Belgium, Italy, Spain